Here is What Hedge Funds Think About Advaxis, Inc. (ADXS)
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 817 active prominent money ...
Posts Tagged ‘NASDAQ:ADXS’
Is Advaxis, Inc. (ADXS) A Good Stock To Buy?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
13G Filing: Adage Capital Management and Advaxis Inc. (ADXS)
Please follow Adage Capital Management (if you aren't already doing so) to get real-time email alerts whenever we publish an article about Adage Capital Management or update its...
How Advaxis, Inc. (ADXS) Stacks Up Against Its Peers
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
Solar and Biotech Stocks Are Leading Today’s Gainers
U.S. stocks opened higher today, with the Dow Jones up by triple digits at one point in time, before turning south and briefly dipping into red.
Advaxis, Inc. (ADXS): Hedge Funds Are Snapping Up
It was a rough third quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 7% during the quarter.
Hedge Funds Think Only 1 Of These 3 Trending Stocks Is Worth Buying
Shares of Advaxis, Inc. (NASDAQ:ADXS), Nu Skin Enterprises, Inc. (NYSE:NUS), and Dex Media Inc (NASDAQ:DXM) are making big moves in the wrong direction, for various reasons.
Broadfin Capital Increases Its Profitable Stake In Advaxis Inc. (ADXS) To 5.27%
As disclosed in a Schedule 13G filing with the U.S.
Advaxis, Inc. (ADXS) Down 10% Today: What Do Hedge Funds Think about this Stock?
Advaxis, Inc. (NASDAQ:ADXS) is a biotechnology company which focuses on developing drug technology for treating Cancer. Alongside many other biotech stocks, Advaxis, Inc.
Alere Inc (ALR), Lion Biotech (LBIO), Genocea Biosciences Inc (GNCA), Advaxis Inc (ADXS) Among Broadfin’s Top New Health Picks
Broadfin Capital, LLC is a New York-based hedge fund, whose $1.28-billion equity portfolio is invested in healthcare companies.
